MedPath

Japan Morning Surge-1 Study

Phase 4
Completed
Conditions
Hypertension
Registration Number
NCT00285519
Lead Sponsor
Japan Heart Foundation
Brief Summary

The purpose of this study is to examine whether strict blood pressure (BP) control by doxazosin using home BP monitoring, especially targeting the morning BP level, can reduce hypertensive target organ damage.

Detailed Description

Morning blood pressure may play an important role in the pathogenesis of hypertensive target organ damage. Increased sympathetic nerve activity is reported to be one of the mechanisms of morning hypertension; however, there are no available data that show whether strict home blood pressure control, especially in the morning period, can reduce target organ damage.We will evaluate whether strict morning blood pressure control by sympathetic nervous system blockade using an alfa-blocker, doxazosin, and with the addition of a beta-blocker if needed, can reduce hypertensive target organ damage.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Morning systolic blood pressure >135 mmHg in a sitting position at home while on stable antihypertensive medication for at least 3 months
Exclusion Criteria
  • History of heart failure
  • Presence of orthostatic hypotension, dementia, malignancy and chronic inflammatory disease
  • Taking an alfa-blocker or beta-blocker
  • Atrial fibrillation or atrial flutter

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
brain natriuretic peptide and the urinary albumin excretion/creatinine ratio at 6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine

🇯🇵

Shimotsuke, Tochigi, Japan

© Copyright 2025. All Rights Reserved by MedPath